The role of IL-18 in Behcet's disease; a potential therapeutic target.

Prasinou, Maria; Smith, Rona; Vrettos, Apostolos; Jayne, David R W

Prasinou, Maria; Smith, Rona; Vrettos, Apostolos; Jayne, David R W.

Afiliação

Prasinou M; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; Department of Medicine, University of Cambridge, Cambridge, United Kingdom. Electronic address: m.prasinou@hotmail.com.
Smith R; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; Department of Medicine, University of Cambridge, Cambridge, United Kingdom. Electronic address: ronasmith@doctors.org.uk.
Vrettos A; Imperial College Healthcare NHS Trust, London, United Kingdom. Electronic address: a.vrettos@nhs.net.
Jayne DRW; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; Department of Medicine, University of Cambridge, Cambridge, United Kingdom. Electronic address: dj106@cam.ac.uk.

Autoimmun Rev ; 19(9): 102613, 2020 Sep.

Article em En | MEDLINE | ID: mdl-32663625

Assuntos

Síndrome de Behçet/tratamento farmacológico; Síndrome de Behçet/imunologia; Interleucina-18/imunologia; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Behçet / Interleucina-18 Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google